Sonoma Pharmaceuticals (SNOA) Change in Cash (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Change in Cash of -$162000.0 for Q1 2026, down 217.39% year-over-year from $138000.0 in Q1 2025, and up 65.82% quarter-over-quarter from -$474000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Change in Cash (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at -$162000.0 for Q1 2026.
- In Q1 2026, Change in Cash fell 217.39% year-over-year to -$162000.0; the TTM figure through Mar 2026 stood at -$3.0 million (down 232.46% YoY), while the FY2026 annual figure was -$3.0 million, down 232.46% from the prior year.
- Change in Cash for Q1 2026 stood at -$162000.0, up from -$474000.0 in the prior quarter.
- The five-year high for Change in Cash was $1.5 million in Q3 2024, with the low at -$2.2 million in Q3 2022.
- The 5-year median for Change in Cash is -$474000.0 (2025), against an average of -$360588.2.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 623.36% in 2022, then soared 330.48% in 2024.
- Sonoma Pharmaceuticals' Change in Cash stood at -$717000.0 in 2022, then surged by 137.52% to $269000.0 in 2023, then jumped by 330.48% to $1.2 million in 2024, then tumbled by 140.93% to -$474000.0 in 2025, then jumped by 65.82% to -$162000.0 in 2026.
- Business Quant data shows SNOA's Change in Cash at -$162000.0 in Q1 2026, -$474000.0 in Q4 2025, and -$570000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | -162,000.00 |
| Dec 31, 2025 | -474,000.00 |
| Sep 30, 2025 | -570,000.00 |
| Jun 30, 2025 | -1.77 Mn |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | -539,000.00 |
| Mar 31, 2024 | 722,000.00 |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | -276,000.00 |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | -717,000.00 |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -1.81 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | 137,000.00 |
| Sep 30, 2021 | 5.58 Mn |